BIOFLOW-III Israel Satellite Registry
NCT01895712 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2017-09-28
Summary
BIOTRONIK - SaFety and Performance Registry for a diabetic patient population with the .bimus Eluting Orsiro Stent System Within daily clinical practice - III
Conditions
- Coronary Artery Disease
- Myocardial Ischemia
- Diabetes Mellitus Type 1 or 2
Sponsors & Collaborators
-
BIOTRONIK Israel
lead INDUSTRY
Principal Investigators
-
Ran Kornowski, Prof · Rabin Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Israel
Study Locations
More Related Trials
-
BIOFLOW III Satellite-ELADIS Orsiro Stent System
NCT02029092 ·Status: COMPLETED
-
BIOFLOW III Satellite-Italy Orsiro Stent System
NCT02028728 ·Status: COMPLETED
-
BIOFLOW III Asia Registry Orsiro Stent System
NCT01941290 ·Status: COMPLETED
-
BIOFLOW-SV All Comers Registry
NCT03600948 ·Status: TERMINATED
-
BIOFLOW-SV Portugal Registry
NCT03600961 ·Status: TERMINATED
-
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139 ·Status: COMPLETED ·Phase: NA
-
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
NCT01939249 ·Status: UNKNOWN ·Phase: NA
-
Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent
NCT03263260 ·Status: COMPLETED
-
INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique
NCT03780192 ·Status: UNKNOWN
-
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT06779630 ·Status: RECRUITING ·Phase: NA
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946 ·Status: COMPLETED ·Phase: NA
-
Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE
NCT03471234 ·Status: COMPLETED
-
Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)
NCT00146575 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
BIONICS Israel Trial
NCT02834806 ·Status: COMPLETED ·Phase: NA
-
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
NCT01995487 ·Status: COMPLETED ·Phase: NA
-
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
NCT01879358 ·Status: UNKNOWN ·Phase: NA
-
Asian Registry of the BioFreedom Stent for STEMI Patients
NCT03609346 ·Status: COMPLETED
-
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
NCT02579031 ·Status: COMPLETED ·Phase: NA
-
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
NCT00231257 ·Status: COMPLETED ·Phase: PHASE3
-
Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)
NCT00133237 ·Status: COMPLETED ·Phase: PHASE4
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent
NCT02568462 ·Status: UNKNOWN ·Phase: PHASE2
-
Biofreedom Stent in All Comer Population
NCT02858739 ·Status: COMPLETED